Association between advanced glycation end‐products and fall risk in older adults: The Yakumo Study

Hiroki Iida,Yasuhiko Takegami,Yusuke Osawa,Hiroto Funahashi,Yuto Ozawa,Hiroaki Ido,Takamune Asamoto,Keiji Otaka,Shinya Tanaka,Hiroaki Nakashima,Shinya Ishizuka,Taisuke Seki,Yukiharu Hasegawa,Shiro Imagama
DOI: https://doi.org/10.1111/ggi.14871
2024-04-23
Geriatrics and Gerontology International
Abstract:The optimal cutoff value of the advanced glycation end‐products for fall risk in patients aged ≥65 years is 2.4. Aim Advanced glycation end‐products (AGEs) are irreversibly and heterogeneously formed compounds during the non‐enzymatic modification of macromolecules, such as proteins. Aging and lifestyle habits, such as high‐fat and high‐protein diets, and smoking, promote AGEs accumulation. This study aimed to investigate the relationship between fall risk and AGEs in community‐dwelling older adults. Methods This cross‐sectional study included patients from the 2022 Yakumo Study who were evaluated for fall risk index 5‐items version, locomotive syndrome stage and AGEs. AGEs were evaluated using Skin autofluorescence (SAF) measured by the AGE reader (DiagnOptics Technologies BV, Groningen, the Netherlands). We divided the participants into two groups according to the presence or absence of fall risk (fall risk index 5‐items version ≥6 or not), and investigated the factors associated with fall risk. Results The fall risk group had a higher age and SAF, and a higher proportion of locomotive syndrome stage >2 than the without fall risk group in patients aged ≥65 years (P
geriatrics & gerontology,gerontology
What problem does this paper attempt to address?